相关实验视频

Updated: Jul 24, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

长循环和向性脂质体共载西斯普拉丁和米法穆尔提德:在骨髓瘤细胞中的配方和输送

Bo Li¹, Qianhui Zhao², Hanyu Yang²

¹Department of Musculoskeletal Tumor, Gansu Provincial Hospital, Lanzhou, China.

AAPS PharmSciTech

|November 26, 2024

概括

研究人员开发了向性脂质体共载西斯 (DDP) 和米法穆尔提德来治疗骨髓瘤 (OS). 这种新型药物递送系统通过改善细胞吸收和抑制癌细胞生长和迁移来增强抗瘤效应.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

骨髓瘤 (OS) 是一种高度恶性骨癌,预后不佳,需要创新的治疗策略.
米法穆尔提德与诸如西斯普拉丁 (DDP) 等化疗剂结合使用,在改善OS患者的治疗结果方面表现有前途.

研究的目的:

构建和评估一种新型药物输送系统,用于共同装载DDP和mifamurtide.
用MMP14向 (BCY-B) 来修改长循环的向性脂质体,以增强OS治疗.

主要方法:

脂质体使用大豆莱西丁 (SPC),胆固醇 (Chol) 和DSPE-PEG配制,并使用BCY-B表面修饰.
进行了脂质体的表征,细胞吸收研究,内细胞突变路径分析,以及MG-63细胞细胞活力,迁移,入侵和亡的体外评估.

主要成果:

构建的脂质体表现出典型的脂质体特征和对MG-63细胞的高度亲和力,从而导致有效的细胞吸收.
多种依赖能量的内细胞细胞分裂路径,包括洞穴介导,克拉介导和巨皮细胞分裂路径,都参与了细胞吸收.
同载脂质体显著抑制了MG-63细胞的活力,迁移和入侵,同时还促进了细胞亡,从而增强了DDP和mifamurtide在体外的联合抗瘤疗效.

结论:

开发的脂质体药物递送系统有效地共载DDP和米法穆尔提德.
该系统促进了活跃瘤向,并证明了体外改善的抗瘤活性,为骨髓瘤治疗提供了一个有前途的新策略.

关键词:

在MMP14中,MMP14是MMP14中的一个.这就是OS OS OS OS.西斯普拉丁 (cisplatin) 是一种制剂.脂质体是一种脂质体.这就是米法穆尔蒂德.

更多相关视频

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...